Peptide record

TPDB43652

Antiviral standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43652
Antiviral
Anti-infective peptides
AI4AVP Peptipedia
standard
No
A 16-aa standard-residue antiviral peptide sequence curated from AI4AVP and Peptipedia, with an available 3D structural model.
Sequence
CDVIALLACHLNTPSF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C76H121N19O22S2
REQGKMWY
L
1717.03
4.94
1
1
8
-1
-0.43
1.138
128.12
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
125
0.07
5
Residue Composition
number
2
A
0
R
1
N
1
D
2
C
0
E
0
Q
0
G
1
H
1
I
3
L
0
K
0
M
1
F
1
P
1
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 1 D: 1 C: 2 E: 0 Q: 0 G: 0 H: 1 I: 1 L: 3 K: 0 M: 0 F: 1 P: 1 S: 1 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
16 reviewed residue count
C76H121N19O22S2 sequence-only estimate (linear, free termini)
1717.03 sequence-only estimate (linear, free termini)
4.94 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
-0.43 sequence-only estimate (linear, free termini)
1.138 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA